Hygea Medical Technology

Hygea Medical Technology has developed and commercialized advanced cryosurgery systems for minimally invasive tumor treatment. Their flagship product, the "Co-Ablation System," integrates both cryoablation and hyperthermia ablation technologies into a single device. The system has obtained CE Marking Certificate in Europe and Class III medical device approval in China. Clinical use includes thousands of patients treated across top hospitals; their technology has won multiple awards including the iF DESIGN AWARD and First Prize of Beijing Science and Technology Award. The company’s devices are used under imaging guidance to precisely target solid tumors with visible/measurable treatment zones.